Amica Mutual Insurance Co. Trims Stake in HealthEquity, Inc. (NASDAQ:HQY)

Amica Mutual Insurance Co. decreased its holdings in shares of HealthEquity, Inc. (NASDAQ:HQY) by 23.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 21,728 shares of the company’s stock after selling 6,823 shares during the quarter. Amica Mutual Insurance Co.’s holdings in HealthEquity were worth $1,441,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Sheets Smith Wealth Management increased its stake in HealthEquity by 2.5% in the third quarter. Sheets Smith Wealth Management now owns 7,921 shares of the company’s stock valued at $579,000 after acquiring an additional 191 shares during the last quarter. Rosenbaum Jay D. bought a new stake in HealthEquity in the 3rd quarter worth approximately $219,000. Raymond James & Associates lifted its position in HealthEquity by 11.1% in the 3rd quarter. Raymond James & Associates now owns 172,747 shares of the company’s stock worth $12,619,000 after buying an additional 17,317 shares during the last quarter. Redwood Investments LLC purchased a new stake in HealthEquity in the third quarter worth approximately $12,377,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank grew its position in HealthEquity by 14.1% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 16,913 shares of the company’s stock valued at $1,235,000 after acquiring an additional 2,085 shares during the last quarter. 99.55% of the stock is currently owned by institutional investors.

HealthEquity Stock Up 0.0 %

HQY traded up $0.04 on Monday, hitting $80.30. The company had a trading volume of 323,261 shares, compared to its average volume of 594,900. The stock has a fifty day simple moving average of $81.01 and a 200-day simple moving average of $74.49. The company has a debt-to-equity ratio of 0.43, a current ratio of 4.76 and a quick ratio of 4.76. The firm has a market capitalization of $6.89 billion, a P/E ratio of 125.00, a P/E/G ratio of 1.31 and a beta of 0.53. HealthEquity, Inc. has a 52-week low of $48.86 and a 52-week high of $84.49.

HealthEquity (NASDAQ:HQY) last released its earnings results on Tuesday, March 19th. The company reported $0.50 EPS for the quarter, beating analysts’ consensus estimates of $0.42 by $0.08. HealthEquity had a return on equity of 6.91% and a net margin of 5.57%. The company had revenue of $262.39 million during the quarter, compared to analysts’ expectations of $258.56 million. As a group, equities analysts expect that HealthEquity, Inc. will post 2.12 EPS for the current fiscal year.

Insider Buying and Selling at HealthEquity

In related news, CEO Jon Kessler sold 33,765 shares of the business’s stock in a transaction dated Friday, March 22nd. The shares were sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the sale, the chief executive officer now owns 126,635 shares of the company’s stock, valued at $10,106,739.35. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other HealthEquity news, CEO Jon Kessler sold 33,765 shares of HealthEquity stock in a transaction on Friday, March 22nd. The stock was sold at an average price of $79.81, for a total transaction of $2,694,784.65. Following the completion of the transaction, the chief executive officer now owns 126,635 shares in the company, valued at $10,106,739.35. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Evelyn S. Dilsaver sold 32,500 shares of the stock in a transaction that occurred on Tuesday, March 26th. The shares were sold at an average price of $79.29, for a total transaction of $2,576,925.00. Following the sale, the director now owns 32,123 shares in the company, valued at approximately $2,547,032.67. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 71,322 shares of company stock valued at $5,682,895. 2.70% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on the stock. BTIG Research upped their price objective on shares of HealthEquity from $100.00 to $110.00 and gave the company a “buy” rating in a research note on Wednesday, March 20th. JMP Securities assumed coverage on shares of HealthEquity in a research report on Thursday, April 4th. They set a “mkt outperform” rating and a $101.00 price target for the company. Royal Bank of Canada lifted their price objective on HealthEquity from $90.00 to $92.00 and gave the stock an “outperform” rating in a report on Wednesday, March 20th. Barclays increased their target price on HealthEquity from $84.00 to $104.00 and gave the company an “overweight” rating in a report on Friday, February 23rd. Finally, KeyCorp lifted their price target on HealthEquity from $85.00 to $95.00 and gave the stock an “overweight” rating in a research note on Friday, March 22nd. One investment analyst has rated the stock with a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $96.17.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.